Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: Stronger association with small artery disease

Neurological Sciences

Volumn 26, Issue 5, 2005, Pages 310-318

  Perini, Francesco ^a,b   Galloni, E ^b   Bolgan, I ^b   Bader, G ^b   Ruffini, R ^b   Arzenton, E ^b   Alba, S ^b   Azzini, C ^b   Bartolomei, L ^b   Billo, G ^b   Bortolon, F ^b   Dudine, P ^b   Garofalo, P G ^b   L'Erario, R ^b   Morra, M ^b   Parisen, P ^b   Stenta, G ^b   Toso, V ^b  

^a Department of Neurology   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Homocysteine; Outcome; Risk; Severity; Stroke

Indexed keywords

HOMOCYSTEINE;

ACUTE DISEASE; ADULT; AGED; ARTERY DISEASE; ARTICLE; BARTHEL INDEX; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANKIN SCALE; RATING SCALE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CASE-CONTROL STUDIES; CEREBRAL ARTERIAL DISEASES; CEREBROVASCULAR ACCIDENT; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 30744464594     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-005-0505-7     Document Type: Article

References (43)

1. McCully KS (1969) Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:11-128
2. Christen WG, Ajani UA, Glynn RJ, Hennekens CH (2000) Blood levels of homocysteine and increased risks of cardiovascular disease: Causal or casual? Arch Int Med 160:422-434
3. Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S (1999) Homocysteine and cardiovascular disease: A critical review of epidemiological evidence. Ann Intern Med 131:363-375
4. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L (1998) Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis. Circulation 98:2520-2526
5. Aronow WS, Ahn C, Gutstein H (2000) Increased plasma homocysteine is an independent predictor of new atherothrombotic brain infarction in older persons. Am J Cardiol 86:585-586
6. Perry IJ, Refsum H, Morris RW, Ebrahim, Ueland PM, Shaker AG (1995) Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346:1395-1398
7. Israelsson B, Brattstrom L, Refsum H (1993) Homocysteine in frozen plasma samples. A short cut to establish hyperhomocysteinaemia as a risk factor for arteriosclerosis? Scand J Clin Lab Invest 53:465-469
8. Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J, Rosenberg IH (1996) Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 348:1120-1124
9. Bostom AG, Rosenberg IH, Silbershtz H et al (1999) Nonfasting plasma homocysteine and stroke incidence in elderly persons: Framingham Study. Ann Intern Med 131:352-355
10. Bots ML, Launer LJ, Lindemans J, Hoes AW, Hofman A, Witteman JC, Koudstaal PJ, Grobbee DE (1999) Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: The Rotterdam Study. Arch Intern Med 159:38-44
11. Alfthan G, Pekkanen J, Jauhiainen M, Pitkaniemi J, Karvonen M, Tuomilhto J, Salonen JT, Ehnholm C (1994) Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 106:9-19
12. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ (1994) A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 25:1924-1930
13. Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 288:2015-2022
14. Li Z, Sun L, Zhang H, Liao Y, Wang D, Zhao B, Zhu Z, Zhao J, Ma A, Han Y, Wang Y, Shi Y, Ye J, Hui R; Multicenter Case-Control Study in China (2003) Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: A Multicenter Case-Control Study in China. Stroke 34:2085-2090
15. Tan NC, Venketasubramanian N, Saw SM, Tjia HT (2002) Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults. Stroke 33:1956-1962
16. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP (2002) Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 33:2351-2356
17. Shimizu H, Kiyohara Y, Kato I, Tanizaki Y, Ueno H, Kimura Y Iwamoto H, Kubo M, Arima H, Ibayashi S, Fujishima M (2002) Plasma homocyst(e)ine concentrations and the risk of subtypes of cerebral infarction. The Hisayama study. Cerebrovasc Dis 13:9-15
18. Candito M, Bedoucha P, Mahagne MH, Scavini G, Chatel M (1997) Total plasma homocysteine determination by liquid chromatography before and after methionine loading. Results in cerebrovascular disease. J Chromatogr B Biomed Sci Appl 692:213-217
19. Hultberg B, Andersson A, Lindgren (1997) A. Marginal folate deficiency as a possible cause of hyperhomocysteinaemia in stroke patients. Eur J Clin Chem Clin Biochem 35:25-28
20. Brattstrom L, Lindgren A, Israelsson B, Malinow MR, Norrving B, Upson B, Hamfelt A (1992) Hyperhomocysteinaemia in stroke: Prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest 22:214-221
21. Yoo JH, Lee SC (2001) Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis 158:425-430
22. Araki A, Sako Y, Fukushima Y, Matsumoto M, Asada T, Kita T (1989) Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis 79:139-146
23. Moller J, Nielsen GM, Tvedegaard KC, Andersen NT, Jorgensen PE (2000) A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. Scand J Clin Lab Invest 60:491-499
24. Lindgren A, Brattstrom L, Norrving B, Hultberg B, Andersson A, Johansson BB (1995) Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 26:795-800
25. Meiklejohn DJ,Vickers MA, Dijkhuisen R, Greaves M (2001) Plasma homocysteine concentrations in the acute and convalescent periods of atherothrombotic stroke. Stroke 32:57-62
26. Howard VJ, Sides EG, Newman GC, Cohen SN, Howard G, Malinow MR, Toole JF (2000) Changes in plasma homocyst(e)ine in the acute phase after stroke. Stroke 33:473-478
27. Dudman NPB (1999) An alternative view of homocysteine. Lancet 354:2072-2074
28. Pezzini A, Del Zotto E, Archetti S, Negrini R, Bani P, Albertini A, Grassi M, Assanelli D, Gasparotti R, Vignolo LA, Magoni M, Padovani A (2002) A plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke 33:664-669
29. Parnetti L, Caso V, Santucci A, Corea F, Lanari A, Floridi A, Conte C, Bottiglieri T (2004) Mild hyperhomocysteinemia is a risk factor in all etiological subtypes of stroke. Neurol Sci 25:13-17
30. Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI (2000) Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 31:1069-1075
31. Pasini FL, Frigerio C, Petri S, Di Perri T (1995) Plasma homocysteine in ischemic stroke. Stroke 26:2374-2375
32. Fasbender K, Mielke O, Bertsch T, Nafe B et al (1999) Homocysteine in cerebral macroangiopathy and microangiopathy. Lancet 353:1586-1587
33. Evers S, Koch HG, Grotemeyer KH, Lange B, Deufel T, Ringelstein EB (1997) Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia. Arch Neurol 54:1276-1282
34. Kristensen B, Malm J, Nilsson TK, Hultdin J, Carlberg B, Dahlen G, Olsson T (1999) Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke. Stroke 30:974-980
35. Scandinavian Stroke Study Group (1985) Multicenter trial of hemodilution in ischemic stroke: Background and study protocol. Stroke 16:885-890
36. Mahoney FI, Barthel DW (1965) Functional evaluation: The Barthel Index. Md State Med J 24:61-69
37. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijin J (1998) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604-607
38. Adams Jr HP and the TOAST Investigators (1993) Classification of subtype of acute ischemic stroke. Stroke 24:35-41
39. Abbate R, Sardi I, Pepe G, Marcucci R, Brunelli T, Prisco D, Fatini C, Capanni M, Simonetti I, Gensini GF (1997) The high prevalence of thermolabile 5-10 methylenetetrahydrofolatereductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD). Thromb Haemost 79:727-730
40. Holven KB, Halvorsen B, Schulz H, Aukrust P, Ose L, Nenseter MS (2003) Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects. Eur J Clin Invest 33:555-560
41. He K, Merchant A, Rimm EB, Rosner BA, Stampfer MJ, Willet WO, Ascherio A (2004) Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke 35:169-174
42. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291:565-575
43. Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, de Garmo P (1990) Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 21:572-576